August 29, 2007 — ReBuilder Medical Technologies Inc. announced it has negotiated an exclusive license from Molluscum Medical Technologies Inc. for the nano silver and electronic based technology to treat the highly contagious skin disease, Molluscum Contagiosum.
With the introduction of the nano-silver treatment in January of 2006, Molluscum Medical Technologies has seen significant growth in the past 12 months with sales jumping from more than $200,000 to $600,000, and continuing to climb. Molluscum Contagiosum appears as small warts, boils or pimples that have a translucent core. It is highly contagious and is transmitted sexually in adults. In children it is transmitted through play, swimming pools, shared towels and athletic equipment. Up to now there has been no cure for the disease.
Currently available treatments in doctors' offices include cutting, burning, or freezing off the lesions. This is very painful and leaves the patient open to opportunistic secondary bacterial infections. Prescription ointments are sometimes offered, but these can burn the surrounding skin, leaving this previously healthy tissue vulnerable to cross contamination.
Molluscum Contagiosum is growing quickly all around the world. Pediatricians have reported that approximately 10 percent of the new patients they see are diagnosed with this skin disease. Molluscum Medical Technologies Inc. has developed a non-invasive treatment (www.molluscum.com) that uses nano silver and a small battery powered device to stop the infection painlessly. ReBuilder Medical has been manufacturing the company's products on a subcontracting basis for the past three years.